Exploiting Synthetic Lethal Interactions Between DNA Damage Signaling, Checkpoint Control, and p53 for Targeted Cancer Therapy
Authors:
- Michael B. YaffeMYMichael B. Yaffe
- 1 January 2012
- book chapter
- Published by Elsevier
- Vol. 110, 289-314
Abstract
No abstract availableKeywords
This publication has 135 references indexed in Scilit:
- 14-3-3 proteins as signaling integration points for cell cycle control and apoptosisSeminars in Cell & Developmental Biology, 2011
- DNA Damage Activates a Spatially Distinct Late Cytoplasmic Cell-Cycle Checkpoint Network Controlled by MK2-Mediated RNA StabilizationMolecular Cell, 2010
- In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in GlioblastomaCancer Cell, 2010
- A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignanciesCancer Chemotherapy and Pharmacology, 2010
- A Genome-wide siRNA Screen Reveals Diverse Cellular Processes and Pathways that Mediate Genome StabilityMolecular Cell, 2009
- A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras OncogeneCell, 2009
- Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2Current Opinion in Cell Biology, 2009
- Principles of Cancer Therapy: Oncogene and Non-oncogene AddictionCell, 2009
- p53-Deficient Cells Rely on ATM- and ATR-Mediated Checkpoint Signaling through the p38MAPK/MK2 Pathway for Survival after DNA DamageCancer Cell, 2007
- The Hallmarks of CancerCell, 2000